Gonadotropin-releasing hormone
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Jan 1, 2002 (NCT00386022)
Timeline
Indications
Mechanism of action
GNRHR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nal-glu gnrh
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00448747 | Phase 3 | Jun 30, 2007 | AEterna Zentaris, Harvard University |
| NCT00351416 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2004 | Harvard University, National Institutes of Health (NIH) |
| NCT00386022 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2002 | Harvard University, National Institute on Aging (NIA) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 3 | 2 | 2 | 2002 |
| AEterna Zentaris | For profit | 1 | 1 | 1 | 2007 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2002 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2004 |
4 organizations
Page 1 / 1